WOCKHARDT GETS USFDA NOD

Search News

Pharma major Wockhardt has said that it has received approval from the US drug regulator for marketing its antiepileptic tablet Levetiracentam in that country. The company has received approval from the United States Food & Drug Administration (USFDA) for marketing of Levetiracentam tablets in the strength of 250, 500, 750 mg and 1 gm, Wockhardt said in a filing to the Bombay Stock Exchange. Levetiracentam tablets are used in the treatment of various kinds of epileptic seizures.

Find Lawyer / Law Firm

Extradition Law in India

Every time an offender stealthily leaves India to take refuge in another country, the Government of India starts all over again with its strategy of bringing him back to the nation to make him stan More

Legal Consultation - Consult over phone, chat or send questions

Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion  More